Bankole A. Johnson
CIK 1718158 · Chief Medical Officer · last filed 2023-06-02
Bankole A. Johnson is a Chief Medical Officer who has filed 10 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing, for ADILW, was dated Jun 2, 2023. Across all open-market trades the lifetime net is −$707.9K, making them a net seller over the disclosed history. 2 SEC filings were submitted jointly with En Fidecomiso de Mi Vida 11/23/2010 Trust.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ADILW price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SUITE 495
CHARLOTTESVILLE, VA 22901
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Chief Medical Officer | 149,301 | $0.00 | $134 | -$707.9K | 10 | 2023-06-02 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-02 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-25 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-06 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Mixed | −200,000 | $0 | EDGAR |
| 2021-04-08 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Sell (S) | −150,000 | -$375.0K | EDGAR |
| 2020-08-24 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Sell (S) | −350,000 | -$423.5K | EDGAR |
| 2019-12-13 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Sell (S) | −150,000 | -$150.0K | EDGAR |
| 2019-10-04 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | +3,187 | $0 | EDGAR |
| 2019-04-01 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Buy (P) | +73,100 | $240.6K | EDGAR |
| 2019-03-26 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-13 | ADIAL PHARMACEUTICALS, INC. (ADILW) Delisted | Other (J) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.